Gapping down
In reaction to disappointing earnings/guidance:
- PBYI -35.2%, OLED -26.3%, MDRX -17.8%, WTW -13.1%, GPRO -13.1%, CC -11.1%, ACLS -9.4%, CARB -7.2%, TEX -6.9%, KHC -6.7%, LOCO -6.3%, HYGS -5.8%, AAPL -5.7%, TRMB -5.4%, SHAK -5.1%, EEP -3.5%, BIO -3.4%, ROG -3%, CTRL -2.8%, TDOC -2.2%, CBS -2.1%, RP -1.6%, SRG -1.4%, FTNT -1.1%, SM -1.1%
Other news:
- ADVM -34.9% (provides program updates; announces decision to discontinue the development of ADVM-043 based on review of the ADVANCE Phase 1/2 study)
- MVIS -8.2% (files $60 mln mixed securities shelf offering)
- SYF -7.3% (Synchrony Financial issues statement in response to lawsuit by Walmart (WMT))
- ALKS -5.7% (confirms outcome from FDA Advisory Committe Meeting on NDA for ALKS 5461 for the adjunctive treatment of major depressive disorder)
Analyst comments:
- UPS -0.8% (downgraded to Neutral at Citibank)